Senior insider sale
Chief Executive Officer at NEWAMSTERDAM PHARMA CO N.V. — senior position signals high conviction
$287.0K
12.26K shares
What this filing means
DAVIDSON MICHAEL H. plans to sell 12.26K shares of NEWAMSTERDAM PHARMA CO N.V. valued at approximately $287.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/26/2025ACC: 0001968582-25-000244
DirectorOfficer· Chief Executive Officer
Since Mar 2026
12.26K
Shares to sell
$287.0K
Approx. market value
12.26K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Equity Compensation - RSU Earnout
compensation
3/26/2025
12.26KTotal acquired12.26K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/26/2025 | Equity Compensation - RSU Earnout compensation | 12.26K | — |
| Total | 12.26K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
12.26K
Market value
$287.0K
3/26/2025
Total
Units
12.26K
Value
$287.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/26/2025 | 12.26K | $287.0K | Nasdaq | Planned |
| Total | 12.26K | $287.0K | ||